Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
The latest announcement is out from Guangzhou Baiyunshan Pharmaceutical Holdings Company ( (HK:0874) ).
Guangzhou Baiyunshan Pharmaceutical Holdings Company announced the resignation of Ms. Liu Juyan from her roles as an executive director and a member of the Strategic Development and Investment Committee due to reaching the statutory retirement age. Her departure will not disrupt the Board’s operations or reduce its size below the legal minimum, and a by-election will be conducted to fill her position. The company expressed gratitude for Ms. Liu’s contributions during her tenure.
More about Guangzhou Baiyunshan Pharmaceutical Holdings Company
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited operates in the pharmaceutical industry, focusing on the development, manufacture, and distribution of pharmaceutical products within China.
YTD Price Performance: -2.40%
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $5.66B
Find detailed analytics on 0874 stock on TipRanks’ Stock Analysis page.
